The role of IMP3 and BCL2 in differentiating between irritated seborrheic keratosis, insitu and invasive squamous cell carcinomas of the skin | ||
Benha Medical Journal | ||
Article 18, Volume 39, Special issue (Radiology), May and June 2022, Pages 210-219 PDF (1.33 M) | ||
Document Type: Original Article | ||
DOI: 10.21608/bmfj.2021.87517.1446 | ||
Authors | ||
omneya youssef bassyoni* 1; Nashwa Mohamed Emara2; heba Mohamed rashad3 | ||
1department of pathology ,f aculty of medicine ,Benha univeristy | ||
2Department of Pathology,Faculty of Medicine, BenhaUniversity, Egypt. | ||
3lecturer at pathology department, Benha faculty of medicine, Benha | ||
Abstract | ||
Introduction: The histological distinction between squamous cell carcinoma both in-situ and invasive from their benign mimic; irritated seborrheic keratosis is still a difficulty. The aim of this study is to invistigate the diagnostic utility of Insulin-like growth factor II mRNA-binding protein 3 (IMP3), and B-cell lymphoma 2 (BCL2 ) in differentiating forementioned cutaneous tumors. Materials and Methods: This is a retrospective study to include 50 cases , 25(50%) cases of squamous cell carcinoma (SCC), 10 (20%) cases of squamous cell carcinoma in-situ (SCCIS), and 15 (30%) cases of irradiated seborrheic keratosis (ISK) . The immunohistochemical expression of IMP3and BCL2 was studied . Results: BCL2 was expressed in 12/15(80%) ISK cases compared to 3/10 (30%) in SCCIS and 4/25 (16%) in invasive SCC cases (p < /p> | ||
Keywords | ||
irritated seborrheic keratosis; squamous cell carcinoma; IMP3; BCL2 | ||
Statistics Article View: 282 PDF Download: 542 |